Kellis, Manolis
- Massachusetts Institute of Technology (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,238
- Sustained Excellence
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
NIH Funding · FY2023
Linked Award Amount
$1.9M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#4,238
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kellis, Manolis as a PI. Multi-PI records show the full award amount for context.
- 5R01AG074003-03R01Contact PISingle-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease$1.1Maward amount
- 1R01AG081017-01R01Contact PISingle-cell multi-region dissection of AD-pathogen interactions for HSV-1 and CMV$786.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Kellis, Manolis as a PI.
FY2023 award administered by Massachusetts Institute of Technology (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardMassachusetts Institute of Technology
- 2008$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2009$2M Cumulative Funding
- 2009Entered Top 50% NationallyRanked #2755
- 2009Entered Top 25% NationallyRanked #2755
- 2010$5M Cumulative Funding
- 2012R01 Grant Holder
- 2014$10M Cumulative Funding
- 2014Entered Top 10% NationallyRanked #1866
- 2021$25M Cumulative Funding